116 related articles for article (PubMed ID: 21330682)
1. Selection of drug-laboratory result pairs for an inpatient asynchronous alert program: results of a Delphi survey.
Yu S; Galanter WL; DiDomenico RJ; Borkowsky S; Schiff GD; Lambert BL
Am J Health Syst Pharm; 2011 Mar; 68(5):407-14. PubMed ID: 21330682
[TBL] [Abstract][Full Text] [Related]
2. High-alert medications for pediatric patients: an international modified Delphi study.
Maaskant JM; Eskes A; van Rijn-Bikker P; Bosman D; van Aalderen W; Vermeulen H
Expert Opin Drug Saf; 2013 Nov; 12(6):805-14. PubMed ID: 23931332
[TBL] [Abstract][Full Text] [Related]
3. Developing consensus on hospital prescribing indicators of potential harm for infants and children.
Fox A; Pontefract S; Brown D; Portlock J; Coleman J
Br J Clin Pharmacol; 2016 Aug; 82(2):451-60. PubMed ID: 27038331
[TBL] [Abstract][Full Text] [Related]
4. Developing consensus on hospital prescribing indicators of potential harms amenable to decision support.
Thomas SK; McDowell SE; Hodson J; Nwulu U; Howard RL; Avery AJ; Slee A; Coleman JJ
Br J Clin Pharmacol; 2013 Nov; 76(5):797-809. PubMed ID: 23362926
[TBL] [Abstract][Full Text] [Related]
5. Interrupting providers with clinical decision support to improve care for heart failure.
Blecker S; Austrian JS; Horwitz LI; Kuperman G; Shelley D; Ferrauiola M; Katz SD
Int J Med Inform; 2019 Nov; 131():103956. PubMed ID: 31525580
[TBL] [Abstract][Full Text] [Related]
6. Potentially inappropriate medications in the elderly: a French consensus panel list.
Laroche ML; Charmes JP; Merle L
Eur J Clin Pharmacol; 2007 Aug; 63(8):725-31. PubMed ID: 17554532
[TBL] [Abstract][Full Text] [Related]
7. Use of computer decision support interventions to improve medication prescribing in older adults: a systematic review.
Yourman L; Concato J; Agostini JV
Am J Geriatr Pharmacother; 2008 Jun; 6(2):119-29. PubMed ID: 18675770
[TBL] [Abstract][Full Text] [Related]
8. Development of a Metric to Detect and Decrease Low-Value Prescribing in Older Adults.
Radomski TR; Decker A; Khodyakov D; Thorpe CT; Hanlon JT; Roberts MS; Fine MJ; Gellad WF
JAMA Netw Open; 2022 Feb; 5(2):e2148599. PubMed ID: 35166780
[TBL] [Abstract][Full Text] [Related]
9. Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvement.
Dreischulte T; Grant AM; McCowan C; McAnaw JJ; Guthrie B
BMC Clin Pharmacol; 2012 Feb; 12():5. PubMed ID: 22316181
[TBL] [Abstract][Full Text] [Related]
10. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation.
Lavan AH; Gallagher P; Parsons C; O'Mahony D
Age Ageing; 2017 Jul; 46(4):600-607. PubMed ID: 28119312
[TBL] [Abstract][Full Text] [Related]
11. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions.
Malone DC; Abarca J; Hansten PD; Grizzle AJ; Armstrong EP; Van Bergen RC; Duncan-Edgar BS; Solomon SL; Lipton RB
J Am Pharm Assoc (2003); 2004; 44(2):142-51. PubMed ID: 15098848
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Laboratory Test-Based Clinical Decision Support Tools on Medication Errors and Adverse Drug Events: A Laboratory Medicine Best Practices Systematic Review.
Whitehead NS; Williams L; Meleth S; Kennedy S; Ubaka-Blackmoore N; Kanter M; O'Leary KJ; Classen D; Jackson B; Murphy DR; Nichols J; Stockwell D; Lorey T; Epner P; Taylor J; Graber ML
J Appl Lab Med; 2019 May; 3(6):1035-1048. PubMed ID: 31639695
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of medication-related clinical decision support over-rides in the intensive care unit.
Wong A; Amato MG; Seger DL; Rehr C; Wright A; Slight SP; Beeler PE; Orav EJ; Bates DW
BMJ Qual Saf; 2018 Sep; 27(9):718-724. PubMed ID: 29440481
[TBL] [Abstract][Full Text] [Related]
14. Clinical risk assessment of modelled situations in a pharmaceutical decision support system: a modified e-Delphi exploratory study.
Bouet J; Potier A; Michel B; Mongaret C; Ade M; Dony A; Larock AS; Dufay É
Int J Clin Pharm; 2024 Jun; 46(3):727-735. PubMed ID: 38551750
[TBL] [Abstract][Full Text] [Related]
15. Preventing drug-related morbidity--determining valid indicators.
Morris CJ; Cantrill JA; Hepler CD; Noyce PR
Int J Qual Health Care; 2002 Jun; 14(3):183-98. PubMed ID: 12108529
[TBL] [Abstract][Full Text] [Related]
16. Classification of drugs with different risk profiles.
Saedder EA; Brock B; Nielsen LP; Bonnerup DK; Lisby M
Dan Med J; 2015 Aug; 62(8):A5118. PubMed ID: 26239589
[TBL] [Abstract][Full Text] [Related]
17. Preventability of adverse drug events involving multiple drugs using publicly available clinical decision support tools.
Wright A; Feblowitz J; Phansalkar S; Liu J; Wilcox A; Keohane CA; Seger DL; Bloomrosen M; Kuperman GJ; Bates DW
Am J Health Syst Pharm; 2012 Feb; 69(3):221-7. PubMed ID: 22261944
[TBL] [Abstract][Full Text] [Related]
18. Consensus building for development of outpatient adverse drug event triggers.
Mull HJ; Nebeker JR; Shimada SL; Kaafarani HM; Rivard PE; Rosen AK
J Patient Saf; 2011 Jun; 7(2):66-71. PubMed ID: 21587117
[TBL] [Abstract][Full Text] [Related]
19. 'Modified STOPP-START criteria for Sri Lanka'; translating to a resource limited healthcare setting by Delphi consensus.
Samaranayake NR; Balasuriya A; Fernando GH; Samaraweera D; Shanika LGT; Wanigasuriya JKP; Wijekoon CN; Wanigatunge CA
BMC Geriatr; 2019 Oct; 19(1):282. PubMed ID: 31640572
[TBL] [Abstract][Full Text] [Related]
20. Development of an Electronic Pediatric All-Cause Harm Measurement Tool Using a Modified Delphi Method.
Stockwell DC; Bisarya H; Classen DC; Kirkendall ES; Lachman PI; Matlow AG; Tham E; Hyman D; Lehman SM; Searles E; Muething SE; Sharek PJ
J Patient Saf; 2016 Dec; 12(4):180-189. PubMed ID: 25162206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
